CYTOCHROME-P450-DEPENDENT METABOLISM OF DEXTROMETHORPHAN - FETAL AND ADULT STUDIES

被引:31
作者
JACQZAIGRAIN, E
CRESTEIL, T
机构
[1] HOP ROBERT DEBRE,DEPT CLIN PHARMACOL,PARIS,FRANCE
[2] INSERM,U75,DEPT BIOCHEM,F-75005 PARIS,FRANCE
来源
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 1992年 / 18卷 / 3-4期
关键词
DEXTROMETHORPHAN; DEBRISOQUINE; CYTOCHROME-P450; PHARMACOGENETICS; FETUS; ONTOGENY;
D O I
10.1159/000480616
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dextromethorphan undergoes O-demethylation to dextrorphan and N-demethylation to 3-methoxymorphinan. 3-Hydroxymorphinan, a didemethylated compound, is secondarily formed. The 0-demethylation pathway to dextrorphan is polymorphic and under CYP2D6 genetic control. Adult and fetal studies were performed to characterize the cytochrome P450 families involved in dextromethorphan metabolism and their ontogeny. In adult volunteers in vivo and in vitro studies demonstrate that the 0-demethylation pathway to dextrorphan is dependent on CYP2D6 and is predominant in extensive metabolizers and defective in poor metabolizers of the drug. The N-demethylation pathway to 3-methoxymorphinan is accessory and is dependent on the CYP3A subfamily. In human fetal microsomes, CYP2D6 protein and activity are not detectable until birth, while CYP2D6 RNA is present in significant amounts before birth. CYP3A activity is detectable in large amounts as early as the 17th week of gestation. Fetal and adult members of the CYP3A subfamily have close, although different, properties, as demonstrated by immunoinhibition studies.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 26 条
[2]   GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].
BOOBIS, AR ;
MURRAY, S ;
HAMPDEN, CE ;
DAVIES, DS .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71
[3]   CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547
[4]   IMMUNOQUANTIFICATION OF EPOXIDE HYDROLASE AND CYTOCHROME-P-450 ISOZYMES IN FETAL AND ADULT HUMAN-LIVER MICROSOMES [J].
CRESTEIL, T ;
BEAUNE, P ;
KREMERS, P ;
CELIER, C ;
GUENGERICH, FP ;
LEROUX, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 151 (02) :345-350
[5]   DEXTROMETHORPHAN O-DEMETHYLATION IN LIVER-MICROSOMES AS A PROTOTYPE REACTION TO MONITOR CYTOCHROME-P-450 DB1 ACTIVITY [J].
DAYER, P ;
LEEMANN, T ;
STRIBERNI, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :34-40
[6]   BIOACTIVATION OF THE NARCOTIC DRUG CODEINE IN HUMAN-LIVER IS MEDIATED BY THE POLYMORPHIC MONOOXYGENASE CATALYZING DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P-450 DBL/BUFI) [J].
DAYER, P ;
DESMEULES, J ;
LEEMANN, T ;
STRIBERNI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :411-416
[7]  
DAYER P, 1990, COST B1 EUROPEAN CON, P33
[8]   GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION [J].
JACQZ, E ;
HALL, SD ;
BRANCH, RA .
HEPATOLOGY, 1986, 6 (05) :1020-1032
[9]   DEXTROMETHORPHAN PHENOTYPES DETERMINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE DETECTION [J].
JACQZAIGRAIN, E ;
MENARD, Y ;
POPON, M ;
MATHIEU, H .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 495 :361-363
[10]   SIGNIFICANCE OF CYTOCHROME-P-450 (P-450-HFLA) OF HUMAN-FETAL LIVERS IN THE STEROID AND DRUG OXIDATIONS [J].
KITADA, M ;
KAMATAKI, T ;
ITAHASHI, K ;
RIKIHISA, T ;
KANAKUBO, Y .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (04) :453-456